The impact of temporal variability of biochemical markers PAPP-A and free β-hCG on the specificity of the first-trimester Down syndrome screening: a Croatian retrospective study-Reference-Cited by-同舟云学术

The impact of temporal variability of biochemical markers PAPP-A and free β-hCG on the specificity of the first-trimester Down syndrome screening: a Croatian retrospective study

Published:2010-07-14 Issue:1 Volume:3 Page:
ISSN:1756-0500
Container-title:BMC Research Notes
language:en
Short-container-title:BMC Res Notes

Author:

Tišlarić-Medenjak Dubravka,Zec Ivana,Šimundić Ana-Maria,Sabolović-Rudman Senka,Kos Milan,Megla Željka Bukovec

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1756-0500-3-194.pdf

Reference27 articles.

1. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH: One stop clinic for assessment of fetal risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynaecol. 1999, 107: 1271-1275.

2. Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM: Combined ultrasound and biochemical screening for Down syndrome: a Scotish multicentre stydy. Br J Obstet Gynaecol. 2002, 109: 667-676.

3. Schuchter K, Hafner E, Stangl G, Metzenbauer M, Hofinger D, Philipp K: The first-trimester 'combined-test' for the detection of Down syndrome pregnancies in 4939 uselected pregnancies. Prenat Diagn. 2002, 22: 211-215. 10.1002/pd.288.

4. Muller F, Benatar C, Audibert F, Roussel N, Dreux S, Cuckle H: First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers. Prenat Diagn. 2003, 23: 833-836. 10.1002/pd.700.

5. Wøjdemann KR, Larsen SO, Rode L, Shalmi A, Sunberg K, Christiansen M, Tabor A: First trimester Down syndrome screening: Distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A. Scand J Clin Lab Invest. 2006, 66: 101-112. 10.1080/00365510500406902.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indigenization of the median of markers for Down syndrome screening based on statistical analysis of medical big data;Taiwanese Journal of Obstetrics and Gynecology;2020-07

2. Missed Down Syndrome Cases after First Trimester False-Negative Screening—Lessons to be Learned;Medicina;2020-04-23

3. Evaluación del índice de riesgo del primer trimestre en casos de embarazo múltiple con presencia de un feto perdido;Revista del Laboratorio Clínico;2013-07

4. Performance Evaluation of Biochemical and Ultrasound Markers for the Screening of Chromosomal Numerical Abnormalities in the First Trimester of Pregnancy;Clinical Laboratory;2013

5. Cribado de cromosomopatías fetales en España. Cambios hospitalarios en el periodo 2006–2011;Diagnóstico Prenatal;2013-01